23 min listen
NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
FromNEJM Interviews
NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
FromNEJM Interviews
ratings:
Length:
12 minutes
Released:
Jun 17, 2015
Format:
Podcast episode
Description
Aaron Kesselheim is an associate professor of medicine at Harvard Medical School and a member of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Sarpatwari, J. Avorn, and A.S. Kesselheim. Progress and Hurdles for Follow-on Biologics. N Engl J Med 2015;372:2380-2.
Released:
Jun 17, 2015
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Alan Weil on the states' role in the implementation of the Affordable Care Act. by NEJM Interviews